At one call center in the Philippines, workers help Americans with diabetes or neurological conditions troubleshoot devices that monitor their ...

ST. LOUIS — Kevin Hines has been living in a house without a roof in the days since a tornado ...

Lurbinectedin showed clinical benefit across therapy lines in SCLC, with best responses seen in later lines and with prior immunotherapy ...

New ASCO data highlight presurgical ctDNA as a relapse predictor in early NSCLC and show surgery improves survival over radiation ...

CHAT, a novel 18-item patient-reported questionnaire, shows promise as a clinical and research tool for evaluating cough hypersensitivity in chronic ...

A Stanford-led study shows that a weekend workshop for physicians and their partners significantly reduced burnout and improved relationship satisfaction. ...

Test your knowledge of the NLA Scientific Sessions agenda. The post How many times is LDL-C referenced in the NLA ...

Real-world data show first-line chemo-immunotherapy improves survival and response rates over chemo alone in extensive-stage SCLC, supporting its broader use. ...

The 2025 ASCO Annual Meeting showcased new data on therapies for chronic lymphocytic leukemia, including zanubrutinib, acalabrutinib, and liso-cel. The ...

The National Lipid Association Scientific Sessions 2025 include a focus on severe hypercholesterolemia, including a highlight on familial hypercholesterolemia. The ...